ConductScience.org, home

Paper22305802

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.

Sperling R and 19 others. Lancet Neurol, 2012. Cited by 426 papers, by iCite.

Cite this record

ConductScience Library. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Papers, record 22305802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22305802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
PubMed
Journal
Lancet Neurol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
426
iCite
Relative citation ratio, by iCite
12.9
iCite
Revised in PubMed
2025-05-29
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sperling RReisa
2Salloway SStephen
3Brooks DJDavid J
4Tampieri DDonatella
5Barakos JJerome
6Fox NCNick C
7Raskind MMurray
8Sabbagh MMarwan
9Honig LSLawrence S
10Porsteinsson APAnton P
11Lieberburg IIvan
12Arrighi HMH Michael
13Morris KAKristen A
14Lu YYuan
15Liu EEnchi
16Gregg KMKeith M
17Brashear HRH Robert
18Kinney GGGene G
19Black RRonald
20Grundman MMichael

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Amyloid beta-PeptidesMajor topic
Antibodies, Monoclonal, HumanizedMajor topic
BrainMajor topic
NeuroimagingMajor topic
Aged
Aged, 80 and over
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Retrospective Studies
Risk Factors

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
G1100810Medical Research CouncilUnited KingdomPubMedPubMed
P30 AG062421NIA NIH HHSUnited StatesP30AG062421PubMedNIH RePORTER
P50 AG005134NIA NIH HHSUnited StatesP50AG005134PubMed and NIHNIH RePORTER
G0601846Medical Research CouncilUnited KingdomPubMedPubMed
K24 AG035007NIA NIH HHSUnited StatesK24AG035007PubMed and NIHNIH RePORTER
MC_U120036861Medical Research CouncilUnited KingdomPubMedPubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in22341028ARIA from off-key operas?https://conductscience.org/library/papers/22341028

Source PubMed

Download CSV of comments and corrections

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114755729Clinical manifestations of cerebral amyloid angiopathy-related inflammation.Ann Neurol2004https://conductscience.org/library/papers/14755729PubMed
220548041Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population.Neurology2010https://conductscience.org/library/papers/20548041PubMed
318596154Immunotherapy reduces vascular amyloid-beta in PDAPP mice.J Neurosci2008https://conductscience.org/library/papers/18596154PubMed
418755411Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition.J Stroke Cerebrovasc Dis2008https://conductscience.org/library/papers/18755411PubMed
518378884Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.Neurology2008https://conductscience.org/library/papers/18378884PubMed
67654074Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.Ann Neurol1995https://conductscience.org/library/papers/7654074PubMed
721307170Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study.Stroke2011https://conductscience.org/library/papers/21307170PubMed
821784350Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab.Alzheimers Dement2011https://conductscience.org/library/papers/21784350PubMed
920505438A single ascending dose study of bapineuzumab in patients with Alzheimer disease.Alzheimer Dis Assoc Disord2010https://conductscience.org/library/papers/20505438PubMed
1020153809Amyloid load in nondemented brains correlates with APOE e4.Neurosci Lett2010https://conductscience.org/library/papers/20153809PubMed
1118953056Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.Brain2008https://conductscience.org/library/papers/18953056PubMed
1217452586Course of cerebral amyloid angiopathy-related inflammation.Neurology2007https://conductscience.org/library/papers/17452586PubMed
1314872042Reversible leukoencephalopathy associated with cerebral amyloid angiopathy.Neurology2004https://conductscience.org/library/papers/14872042PubMed
1412787320APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.Neuropathol Appl Neurobiol2003https://conductscience.org/library/papers/12787320PubMed
1521784348Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.Alzheimers Dement2011https://conductscience.org/library/papers/21784348PubMed
1619762705Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition.Stroke2009https://conductscience.org/library/papers/19762705PubMed
1718363936Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.Brain Pathol2008https://conductscience.org/library/papers/18363936PubMed
1821987394Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.Arch Neurol2012https://conductscience.org/library/papers/21987394PubMed
1911387493A new rating scale for age-related white matter changes applicable to MRI and CT.Stroke2001https://conductscience.org/library/papers/11387493PubMed
2021263194Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.J Alzheimers Dis2011https://conductscience.org/library/papers/21263194PubMed

See all 26 referencesDownload CSV of references

Cited by277

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 426 citations.

PMIDTitleJournalYearIn PapersSource
42934592Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report.BMC Neurol2026https://conductscience.org/library/papers/42934592PubMed
42908770Topography and risk factors of amyloid-related imaging abnormality: real-world data from 168 aducanumab-treated patients at a private clinic in South Korea.Alzheimers Dement (Amst)2026https://conductscience.org/library/papers/42908770PubMed
42825842
Incidence, severity, and associated risk factors for amyloid-related imaging abnormalities in anti-amyloid monoclonal antibody therapy for early Alzheimer's disease: a systematic review and meta-analysis.
Neurol Sci2026https://conductscience.org/library/papers/42825842PubMed
42779634Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy.bioRxiv2026https://conductscience.org/library/papers/42779634PubMed
42766053T1 mapping in Alzheimer's disease: a quantitative MRI study with amyloid-PET correlation.Eur Radiol Exp2026https://conductscience.org/library/papers/42766053PubMed
42605139Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis.Brain Behav2026https://conductscience.org/library/papers/42605139PubMed
42459526APOE ε4-associated hippocampal atrophy trajectories across the Alzheimer's disease continuum: a systematic review, meta-analysis, and longitudinal validation.Front Aging Neurosci2026https://conductscience.org/library/papers/42459526PubMed
42440762Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology.Front Psychiatry2026https://conductscience.org/library/papers/42440762PubMed
42363270Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.Mol Neurodegener2026https://conductscience.org/library/papers/42363270PubMed
42301522Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease.Acta Neuropathol2026https://conductscience.org/library/papers/42301522PubMed
42169086Plasma ApoE proteotyping for ApoE ε4 stratification in the anti-amyloid therapies era.Alzheimers Res Ther2026https://conductscience.org/library/papers/42169086PubMed
42040755MRI evaluation of cerebral perivascular spaces predicts amyloid-related imaging abnormalities risk in preclinical Alzheimer's disease.Front Dement2026https://conductscience.org/library/papers/42040755PubMed
42039150Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer's disease therapy.Front Cell Dev Biol2026https://conductscience.org/library/papers/42039150PubMed
42015334Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.Alzheimers Dement2026https://conductscience.org/library/papers/42015334PubMed
41946975The potential of low-field MRI for global dementia care.Nat Rev Neurol2026https://conductscience.org/library/papers/41946975PubMed
41867862Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice.bioRxiv2026https://conductscience.org/library/papers/41867862PubMed
41803942In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences.Alzheimers Res Ther2026https://conductscience.org/library/papers/41803942PubMed
41724678Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy.Alzheimers Dement2026https://conductscience.org/library/papers/41724678PubMed
41571449Amyloid-related imaging abnormalities (ARIA) in Alzheimer's immunotherapy: a framework and challenges for global surveillance strategies.J Neurol Neurosurg Psychiatry2026https://conductscience.org/library/papers/41571449PubMed
41409668APOE ε 4 -Associated Hippocampal Atrophy Trajectories Across the Alzheimer's Disease Continuum: A Systematic Review, Meta-Analysis, and Longitudinal Validation.medRxiv2025https://conductscience.org/library/papers/41409668PubMed

See all 277 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
GK2710PubTator's text mininghttps://conductscience.org/library/genes/2710NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22305802

GET https://conductscience.org/api/papers/v1/22305802/references?page=2